These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38184005)

  • 1. Virological characteristics of the SARS-CoV-2 JN.1 variant.
    Kaku Y; Okumura K; Padilla-Blanco M; Kosugi Y; Uriu K; Hinay AA; Chen L; Plianchaisuk A; Kobiyama K; Ishii KJ; ; Zahradnik J; Ito J; Sato K
    Lancet Infect Dis; 2024 Feb; 24(2):e82. PubMed ID: 38184005
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023.
    Jeworowski LM; Mühlemann B; Walper F; Schmidt ML; Jansen J; Krumbholz A; Simon-Lorière E; Jones TC; Corman VM; Drosten C
    Euro Surveill; 2024 Jan; 29(2):. PubMed ID: 38214083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
    Rubin R
    JAMA; 2024 Feb; 331(5):382-383. PubMed ID: 38214935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults.
    Quarleri J; Delpino MV; Galvan V
    Geroscience; 2024 Jun; 46(3):2879-2883. PubMed ID: 38198026
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and virological features of asymptomatic and mild symptomatic patients with SARS-CoV-2 Omicron infection at Shanghai Fangcang shelter hospital.
    Zhang L; Kang X; Wang L; Yan R; Pan Y; Wang J; Chen Z
    Immun Inflamm Dis; 2023 Sep; 11(9):e1033. PubMed ID: 37773703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy.
    Lo Menzo S; Marinello S; Biasin M; Terregino C; Franchin E; Crisanti A; Cattelan A
    Infection; 2021 Dec; 49(6):1341-1345. PubMed ID: 33840038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.
    Yamasoba D; Uriu K; Plianchaisuk A; Kosugi Y; Pan L; Zahradnik J; ; Ito J; Sato K
    Lancet Infect Dis; 2023 Jun; 23(6):655-656. PubMed ID: 37148902
    [No Abstract]   [Full Text] [Related]  

  • 8. Early detection of the emerging SARS-CoV-2 BA.2.86 lineage through integrated genomic surveillance of wastewater and COVID-19 cases in Sweden, weeks 31 to 38 2023.
    Espinosa-Gongora C; Berg C; Rehn M; Varg JE; Dillner L; Latorre-Margalef N; Székely AJ; Andersson E; Movert E
    Euro Surveill; 2023 Nov; 28(46):. PubMed ID: 37971659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China.
    Ao Y; Li J; Wei Z; Wang Z; Tian H; Qiu Y; Fu X; Ma W; Li L; Zeng M; Xu J
    J Infect; 2022 Nov; 85(5):573-607. PubMed ID: 35934137
    [No Abstract]   [Full Text] [Related]  

  • 10. A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
    Fillâtre P; Dufour MJ; Behillil S; Vatan R; Reusse P; Gabellec A; Velmans N; Montagne C; Geffroy Du Coudret S; Droumaguet E; Merour V; Enouf V; Buzelé R; Valence M; Guillotel E; Gagnière B; Baidaliuk A; Zhukova A; Tourdjman M; Thibault V; Grolhier C; Pronier C; Lescure FX; Simon-Loriere E; Costagliola D; Van Der Werf S; Tattevin P; Massart N
    Clin Microbiol Infect; 2022 Feb; 28(2):298.e9-298.e15. PubMed ID: 34627988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS-CoV-2 spread prior to the first German case in January 2020.
    Eberle U; Heinzinger S; Konrad R; Wimmer C; Liebl B; Katz K; Ackermann N; Sing A;
    Infection; 2021 Oct; 49(5):1029-1032. PubMed ID: 33891281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of immunological & virological factors driving the evolution & global spread of SARS-CoV-2 variants.
    Ramasamy R
    Indian J Med Res; 2023 Sep; 158(3):257-268. PubMed ID: 37815068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in research of epidemiologic feature and control of SARS-CoV-2 Delta variant].
    Du M; Liu M; Liu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1774-1779. PubMed ID: 34814611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study.
    Kang SW; Park H; Kim JY; Lim SY; Lee S; Bae JY; Kim J; Chang E; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Park MS; Kim SH
    J Infect; 2023 May; 86(5):e148-e151. PubMed ID: 36669564
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members.
    Karron RA; Hetrich MK; Na YB; Knoll MD; Schappell E; Meece J; Hanson E; Tong S; Lee JS; Veguilla V; Dawood FS;
    JAMA Netw Open; 2022 Aug; 5(8):e2227348. PubMed ID: 36044218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
    Saito A; Tamura T; Zahradnik J; Deguchi S; Tabata K; Anraku Y; Kimura I; Ito J; Yamasoba D; Nasser H; Toyoda M; Nagata K; Uriu K; Kosugi Y; Fujita S; Shofa M; Monira Begum M; Shimizu R; Oda Y; Suzuki R; Ito H; Nao N; Wang L; Tsuda M; Yoshimatsu K; Kuramochi J; Kita S; Sasaki-Tabata K; Fukuhara H; Maenaka K; Yamamoto Y; Nagamoto T; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Ueno T; Schreiber G; Takaori-Kondo A; ; Shirakawa K; Sawa H; Irie T; Hashiguchi T; Takayama K; Matsuno K; Tanaka S; Ikeda T; Fukuhara T; Sato K
    Cell Host Microbe; 2022 Nov; 30(11):1540-1555.e15. PubMed ID: 36272413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review.
    Fan Q; Nie Z; Xie S
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast-Spreading JN.1: What You Need to Know About the Latest COVID-19 Subvariant.
    Srivastava S; Kumar S; Ashique S; Satapathy P; Mehta R; Mohanty A; Sah R
    J Infect Public Health; 2024 Jul; 17(7):102451. PubMed ID: 38838605
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
    Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
    Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children's medical center in Shanghai, China.
    Shen N; Wu YF; Chen YW; Fang XY; Zhou M; Wang WY; Tang MY; Pan QH; Ma J; Zhang H; Cao Q
    World J Pediatr; 2023 Jan; 19(1):87-95. PubMed ID: 36251118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.